Specific niche view of the structured sector hierarchy. Useful for precedent work where broader sector slices include too much noise.
| Target | Buyer / Investor | Sector | Geo | Transaction size | EV / EBITDA |
|---|---|---|---|---|---|
| Organika Health Products | Archimed | Drug Retailers (NEC) | $120M – $162M | 8× – 11× | |
| Boots | Wittington Investments | Drug Retailers (NEC) | $8,500M | 11× – 14× | |
| Boots | Wittington Investments, Fairfax Financial Holdings | Drug Retailers (NEC) | $8,900M | 19× – 23× | |
| Pet Care Group srl | Giellepi spa | Drug Retailers (NEC) | $1.5M – $2.0M | 5× – 7× | |
| Goodlife | Blue Earth Capital | Drug Retailers (NEC) | $14.0M – $19.0M | 6× – 8× | |
| Walgreens Boots Alliance | Sycamore Partners | Drug Retailers (NEC) | $23,700M | 4× – 5× | |
| Jamieson Wellness Inc. | Kirin Holdings Company, Limited | Drug Retailers (NEC) | $1,800M | 11× – 14× | |
| PetMed Express | CVS Health | Drug Retailers (NEC) | $37.0M | 6× – 8× | |
| Pharmacy2U | G Square Healthcare Private Equity LLP, Coller Capital | Drug Retailers (NEC) | $625M | 9× – 12× | |
| Nature’s Rule | Alta Semper | Drug Retailers (NEC) | $49.0M – $66.0M | 6× – 9× |
Bins are observed deal frequencies across disclosed transactions. Use as a directional reference, not a target valuation.
Use the directory on the recent deals hub to switch between countries, sectors and sub-sectors. A free account unlocks the structured filters that go beyond the public view.